Renal function during treatment with adefovir plus peginterferon alfa-2a vs either drug alone in hepatitis B/D co-infection
Journal of Viral Hepatitis, 05/15/2012Mederacke I et al.
Adefovir–containing but not PegIFNα–2a treatment was associated with a decrease in GFR values in about one–fifth of patients. Combination treatment of PegIFNα–2a+ADV in chronic hepatitis B/D co–infection did not lead to any further impairment of kidney function.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.